Randomized Clinical Trial of Thrice-Weekly 4-Month Moxifloxacin or Gatifloxacin Containing Regimens in the Treatment of New Sputum Positive Pulmonary Tuberculosis Patients

Mohideen S. Jawahar; Vaithilingam V. Banurekha; Chinnampedu N. Paramasivan; Fathima Rahman; Rajeswari Ramachandran; Perumal Venkatesan; Rani Balasubramanian; Nagamiah Selvakumar; Chinnaiyan Ponnuraja; Allaudeen S. Iliayas; Navaneethapandian P. Gangadevi; Balambal Raman; Dhanaraj Baskaran; Santhanakrishnan R. Kumar; Marimuthu M. Kumar; Victor Mohan; Sudha Ganapathy; Vanaja Kumar; Geetha Shanmugam; Niruparani Charles; Murugesan R. Sakthivel; Kannivelu Jagannath; Chockalingam Chandrasekar; Ramavaram T. Parthasarathy; Paranji R. Narayanan

doi:10.1371/journal.pone.0067030

Loading metrics

Open Access

Peer-reviewed

Research Article

Randomized Clinical Trial of Thrice-Weekly 4-Month Moxifloxacin or Gatifloxacin Containing Regimens in the Treatment of New Sputum Positive Pulmonary Tuberculosis Patients

Mohideen S. Jawahar ,

* E-mail: shaheedjawahar@gmail.com

Affiliation National Institute for Research in Tuberculosis (formerly Tuberculosis Research Centre), Chennai, India
⨯
Vaithilingam V. Banurekha,

Affiliation National Institute for Research in Tuberculosis (formerly Tuberculosis Research Centre), Chennai, India
⨯
Chinnampedu N. Paramasivan,

Affiliation National Institute for Research in Tuberculosis (formerly Tuberculosis Research Centre), Chennai, India
⨯
Fathima Rahman,

Affiliation National Institute for Research in Tuberculosis (formerly Tuberculosis Research Centre), Chennai, India
⨯
Rajeswari Ramachandran,

Affiliation National Institute for Research in Tuberculosis (formerly Tuberculosis Research Centre), Chennai, India
⨯
Perumal Venkatesan,

Affiliation National Institute for Research in Tuberculosis (formerly Tuberculosis Research Centre), Chennai, India
⨯
Rani Balasubramanian,

Affiliation National Institute for Research in Tuberculosis (formerly Tuberculosis Research Centre), Chennai, India
⨯
Nagamiah Selvakumar,

Affiliation National Institute for Research in Tuberculosis (formerly Tuberculosis Research Centre), Chennai, India
⨯
Chinnaiyan Ponnuraja,

Affiliation National Institute for Research in Tuberculosis (formerly Tuberculosis Research Centre), Chennai, India
⨯
Allaudeen S. Iliayas,

Affiliation National Institute for Research in Tuberculosis (formerly Tuberculosis Research Centre), Madurai, India
⨯
Navaneethapandian P. Gangadevi,

Affiliation National Institute for Research in Tuberculosis (formerly Tuberculosis Research Centre), Madurai, India
⨯
Balambal Raman,

Affiliation National Institute for Research in Tuberculosis (formerly Tuberculosis Research Centre), Chennai, India
⨯
Dhanaraj Baskaran,

Affiliation National Institute for Research in Tuberculosis (formerly Tuberculosis Research Centre), Chennai, India
⨯
Santhanakrishnan R. Kumar,

Affiliation National Institute for Research in Tuberculosis (formerly Tuberculosis Research Centre), Madurai, India
⨯
Marimuthu M. Kumar,

Affiliation National Institute for Research in Tuberculosis (formerly Tuberculosis Research Centre), Madurai, India
⨯
Victor Mohan,

Affiliation National Institute for Research in Tuberculosis (formerly Tuberculosis Research Centre), Madurai, India
⨯
Sudha Ganapathy,

Affiliation National Institute for Research in Tuberculosis (formerly Tuberculosis Research Centre), Chennai, India
⨯
Vanaja Kumar,

Affiliation National Institute for Research in Tuberculosis (formerly Tuberculosis Research Centre), Chennai, India
⨯
Geetha Shanmugam,

Affiliation National Institute for Research in Tuberculosis (formerly Tuberculosis Research Centre), Chennai, India
⨯
Niruparani Charles,

Affiliation National Institute for Research in Tuberculosis (formerly Tuberculosis Research Centre), Chennai, India
⨯
Murugesan R. Sakthivel,

Affiliation National Institute for Research in Tuberculosis (formerly Tuberculosis Research Centre), Madurai, India
⨯
Kannivelu Jagannath,

Affiliation Institute of Thoracic Medicine, Chennai, India
⨯
Chockalingam Chandrasekar,

Affiliation Government Rajaji Hospital, Madurai, India
⨯
Ramavaram T. Parthasarathy,

Affiliation Government Tiruvatteeswarar Hospital, Chennai, India
⨯
[ ... ],
Paranji R. Narayanan

Affiliation National Institute for Research in Tuberculosis (formerly Tuberculosis Research Centre), Chennai, India
⨯
[ view all ]
[ view less ]

Randomized Clinical Trial of Thrice-Weekly 4-Month Moxifloxacin or Gatifloxacin Containing Regimens in the Treatment of New Sputum Positive Pulmonary Tuberculosis Patients

Mohideen S. Jawahar,
Vaithilingam V. Banurekha,
Chinnampedu N. Paramasivan,
Fathima Rahman,
Rajeswari Ramachandran,
Perumal Venkatesan,
Rani Balasubramanian,
Nagamiah Selvakumar,
Chinnaiyan Ponnuraja,
Allaudeen S. Iliayas

Published: July 3, 2013
https://doi.org/10.1371/journal.pone.0067030

Reader Comments (2)

Post a new comment on this article

1 Response

11 Dec 2013
07:09 GMT
Most Recent

Concerns about the conduct and analysis of this study Posted by rwaldridge on 27 Nov 2013 at 13:55 GMT

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Tuberculosis
Is the Subject Area "Tuberculosis" applicable to this article?

Thanks for your feedback.
Sputum
Is the Subject Area "Sputum" applicable to this article?

Thanks for your feedback.
Mycobacterium tuberculosis
Is the Subject Area "Mycobacterium tuberculosis" applicable to this article?

Thanks for your feedback.
Adverse reactions
Is the Subject Area "Adverse reactions" applicable to this article?

Thanks for your feedback.
Drug administration
Is the Subject Area "Drug administration" applicable to this article?

Thanks for your feedback.
Extensively drug-resistant tuberculosis
Is the Subject Area "Extensively drug-resistant tuberculosis" applicable to this article?

Thanks for your feedback.
Drug research and development
Is the Subject Area "Drug research and development" applicable to this article?

Thanks for your feedback.